エーザイの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2013/01/16 | 3,890 | 3,895 | 3,805 | 3,810 | -65 | -1.7% | 1,638,200 |
| 2013/01/15 | 3,780 | 3,885 | 3,775 | 3,875 | +120 | +3.2% | 1,654,600 |
| 2013/01/11 | 3,695 | 3,760 | 3,695 | 3,755 | +65 | +1.8% | 2,193,000 |
| 2013/01/10 | 3,670 | 3,695 | 3,670 | 3,690 | +10 | +0.3% | 1,021,800 |
| 2013/01/09 | 3,650 | 3,690 | 3,630 | 3,680 | +20 | +0.5% | 1,157,400 |
| 2013/01/08 | 3,630 | 3,665 | 3,625 | 3,660 | +20 | +0.5% | 947,200 |
| 2013/01/07 | 3,640 | 3,650 | 3,630 | 3,640 | +5 | +0.1% | 822,700 |
| 2013/01/04 | 3,655 | 3,670 | 3,630 | 3,635 | +35 | +1% | 1,240,100 |
| 2012/12/28 | 3,640 | 3,650 | 3,600 | 3,600 | -45 | -1.2% | 950,200 |
| 2012/12/27 | 3,615 | 3,650 | 3,610 | 3,645 | +20 | +0.6% | 1,076,600 |
| 2012/12/26 | 3,605 | 3,625 | 3,585 | 3,625 | +30 | +0.8% | 828,000 |
| 2012/12/25 | 3,600 | 3,610 | 3,570 | 3,595 | +10 | +0.3% | 854,400 |
| 2012/12/21 | 3,600 | 3,625 | 3,585 | 3,585 | +30 | +0.8% | 1,715,200 |
| 2012/12/20 | 3,545 | 3,625 | 3,545 | 3,555 | +25 | +0.7% | 2,660,200 |
| 2012/12/19 | 3,535 | 3,540 | 3,510 | 3,530 | +20 | +0.6% | 1,323,000 |
| 2012/12/18 | 3,510 | 3,540 | 3,505 | 3,510 | +5 | +0.1% | 1,031,200 |
| 2012/12/17 | 3,505 | 3,510 | 3,475 | 3,505 | +40 | +1.2% | 1,044,700 |
| 2012/12/14 | 3,500 | 3,510 | 3,455 | 3,465 | -30 | -0.9% | 3,100,500 |
| 2012/12/13 | 3,495 | 3,510 | 3,475 | 3,495 | +20 | +0.6% | 858,500 |
| 2012/12/12 | 3,510 | 3,510 | 3,470 | 3,475 | -30 | -0.9% | 841,700 |
| 2012/12/11 | 3,500 | 3,515 | 3,495 | 3,505 | ±0 | ±0% | 477,700 |
| 2012/12/10 | 3,545 | 3,545 | 3,490 | 3,505 | +5 | +0.1% | 955,900 |
| 2012/12/07 | 3,470 | 3,525 | 3,465 | 3,500 | +35 | +1% | 1,184,800 |
| 2012/12/06 | 3,450 | 3,470 | 3,440 | 3,465 | +25 | +0.7% | 953,300 |
| 2012/12/05 | 3,420 | 3,445 | 3,420 | 3,440 | +10 | +0.3% | 779,700 |
| 2012/12/04 | 3,430 | 3,455 | 3,420 | 3,430 | -5 | -0.1% | 1,041,100 |
| 2012/12/03 | 3,465 | 3,470 | 3,430 | 3,435 | -25 | -0.7% | 1,020,300 |
| 2012/11/30 | 3,440 | 3,460 | 3,420 | 3,460 | +35 | +1% | 1,125,300 |
| 2012/11/29 | 3,415 | 3,430 | 3,400 | 3,425 | +10 | +0.3% | 1,013,900 |
| 2012/11/28 | 3,390 | 3,440 | 3,385 | 3,415 | +35 | +1% | 1,472,900 |
| 2012/11/27 | 3,420 | 3,440 | 3,370 | 3,380 | -5 | -0.1% | 1,454,400 |
| 2012/11/26 | 3,395 | 3,415 | 3,360 | 3,385 | +10 | +0.3% | 1,709,000 |
| 2012/11/22 | 3,385 | 3,390 | 3,355 | 3,375 | +10 | +0.3% | 949,300 |
| 2012/11/21 | 3,370 | 3,380 | 3,345 | 3,365 | +15 | +0.4% | 1,788,200 |
| 2012/11/20 | 3,385 | 3,390 | 3,350 | 3,350 | -25 | -0.7% | 1,260,300 |
| 2012/11/19 | 3,385 | 3,395 | 3,370 | 3,375 | +10 | +0.3% | 950,400 |
| 2012/11/16 | 3,345 | 3,365 | 3,340 | 3,365 | +15 | +0.4% | 1,319,100 |
| 2012/11/15 | 3,365 | 3,365 | 3,330 | 3,350 | +5 | +0.1% | 823,200 |
| 2012/11/14 | 3,345 | 3,375 | 3,340 | 3,345 | +10 | +0.3% | 483,400 |
| 2012/11/13 | 3,365 | 3,380 | 3,330 | 3,335 | -30 | -0.9% | 812,300 |
| 2012/11/12 | 3,405 | 3,405 | 3,360 | 3,365 | -40 | -1.2% | 774,900 |
| 2012/11/09 | 3,425 | 3,435 | 3,400 | 3,405 | -15 | -0.4% | 1,129,400 |
| 2012/11/08 | 3,455 | 3,470 | 3,405 | 3,420 | -70 | -2% | 1,425,400 |
| 2012/11/07 | 3,505 | 3,520 | 3,455 | 3,490 | -30 | -0.9% | 1,294,700 |
| 2012/11/06 | 3,510 | 3,520 | 3,480 | 3,520 | +10 | +0.3% | 845,200 |
| 2012/11/05 | 3,495 | 3,520 | 3,480 | 3,510 | +5 | +0.1% | 856,200 |
| 2012/11/02 | 3,575 | 3,575 | 3,505 | 3,505 | -30 | -0.8% | 842,800 |
| 2012/11/01 | 3,585 | 3,590 | 3,515 | 3,535 | -20 | -0.6% | 1,016,300 |
| 2012/10/31 | 3,540 | 3,565 | 3,505 | 3,555 | +25 | +0.7% | 1,287,200 |
| 2012/10/30 | 3,545 | 3,570 | 3,525 | 3,530 | -10 | -0.3% | 1,027,100 |
2901～
2950
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「エーザイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| エーザイ | 465,000円 | +1.7% | -2.9% | 3.44% | 30.51倍 | 1.60倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 209,400円 | +5.7% | +3.9% | 2.74% | 10.42倍 | 1.38倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| 協和キリン | 252,300円 | +11.3% | -5.4% | 2.30% | 19.42倍 | 1.53倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| 小野薬 | 174,700円 | -3.5% | -50.2% | 4.58% | 14.15倍 | 1.05倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
